A Quote by John Cornforth

In 1962, Popjak and I left the service of the Medical Research Council and became co-directors of the Milstead Laboratory of Chemical Enzymology set up by Shell Research Ltd.
At the National Institute for Medical Research, I came into contact with biological scientists and formed collaborative projects with several of them. In particular, George Popjak and I shared an interest in cholesterol.
In 1998, I set up and directed a research group at the Nanotechnology Institute newly created in the Research Center of Karlsruhe. This allowed to offer to former post-doctoral coworkers the opportunity to develop and to progressively set up independent research activities in nanoscience and nanotechnology.
I grew up in Muenchen where my father has been a professor for pharmaceutic chemistry at the university. He had studied chemistry and medicine, having been a research student in Leipzig with Wilhelm Ostwald, the Nobel Laureate 1909. So I became familiar with the life of a scientist in a chemical laboratory quite early.
I was invited to join the newly established Central Chemical Research Institute of the Hungarian Academy of Sciences in 1954 and was able to establish a small research group in organic chemistry, housed in temporary laboratories of an industrial research institute.
I decided to take two years between finishing undergraduate and beginning medical school to devote fully to medical research. I knew that I wanted to go to medical school during undergraduate, but I was also eager to get a significant amount of research experience.
The space station is the most unique laboratory we've ever built. The reason we have it is to do research on materials, people, medical matters, pharmaceuticals - the possibilities are nearly endless.
Hard as it is to imagine, there's a move afoot in Congress to take away the public's free online access to tax-funded medical research findings. That would be bad for medical discovery, bad for patients looking for the latest research results, and another rip-off of the American taxpayer.
It is ironic that in the same year we celebrate the 50th anniversary of the discovery of DNA, some would have us ban certain forms of DNA medical research. Restricting medical research has very real human consequences, measured in loss of life and tremendous suffering for patients and their families.
My ambition was to bring to bear on medicine a chemical approach. I did that by chemical manipulation of viruses and chemical ways of thinking in biomedical research.
To cure ALS medically is not economical. The realities are that it's difficult to find funding for research for a medical cure. I believe in developing technology as opposed to medical research. Technology can be economical.
To date, embryonic stem cell research has not produced a single medical treatment, where ethical, adult stem cell research has produced some 67 medical miracles.
I teach at Caltech and oversee a research laboratory there. In general, I find that the majority of young people are excited by the prospects of research, but they soon discover that in the current market, many doctorate-level scientists are holding temporary positions or are unemployed.
In 1981, after ten years in Basel, I returned to the United States to continue my research on the immune system at the Center for Cancer Research of the Massachusetts Institute of Technology where Director Salvador E. Luria provided me with an excellent laboratory.
I chose biochemistry as my major and graduated after 4 years with an Honours degree in Biochemistry. During that time, I had come to love biochemistry research, although I was just getting my feet wet in laboratory research.
I've never like had a system or a program, I always think that I don't know how to act. I'll adapt to any director because I don't really have a set way that I do things. If a director hires me and says, "I want you to get started right now and do this research, this research, this research and I want you to have every line memorized before you ever show up for the first day," then that's what I'll do.
I decided to pursue graduate study in molecular biology and was accepted by Professor Itaru Watanabe's laboratory at the Institute for Virus Research at the University of Kyoto, one of a few laboratories in Japan where U.S.-trained molecular biologists were actively engaged in research.
This site uses cookies to ensure you get the best experience. More info...
Got it!